217695
Cdk1 Inhibitor - CAS 220749-41-7 - Calbiochem
The Cdk1 Inhibitor, also referenced under CAS 220749-41-7, controls the biological activity of Cdk1. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.
Sinônimo(s):
Cdk1 Inhibitor - CAS 220749-41-7 - Calbiochem, 3-(2-Chloro-3-indolylmethylene)-1,3-dihydroindol-2-one
Faça loginpara ver os preços organizacionais e de contrato
About This Item
Fórmula empírica (Notação de Hill):
C17H11ClN2O
Número CAS:
Peso molecular:
294.74
Código UNSPSC:
12352200
Nível de qualidade
Ensaio
≥95% (HPLC)
Formulário
solid
fabricante/nome comercial
Calbiochem®
condição de armazenamento
OK to freeze
protect from light
cor
orange
solubilidade
DMSO: 200 mg/mL
Condições de expedição
ambient
temperatura de armazenamento
2-8°C
Descrição geral
A cell-permeable indolylmethylene-2-indolinone derivative that exhibits potent anti-proliferative properties (IC50 = 2 µM HeLa cells). Acts as a selective, reversible and ATP-competitive inhibitor of Cdk1/cyclin B (IC50 = 5.8 µM). Also inhibits Cdk5 with a IC50 = 25 µM. Binds to the ATP pocket on the Cdk1 active site. Does not affect the activity of GSK-3β even at 100 µM concentrations.
A cell-permeable indolylmethylene-2-indolinone derivative that exhibits potent anti-proliferative properties (IC50 = 2 µM in HeLa cells). Acts as a selective, reversible and ATP-competitive inhibitor of cyclin-dependent kinase-1/cyclin B (IC50 = 5.8 µM for Cdk1 and 25 µM for Cdk5). Does not affect the activity of GSK-3β even at 100 µM concentrations. Binds to the ATP pocket in the Cdk1 active site.
Ações bioquímicas/fisiológicas
Cell permeable: yes
Primary Target
Cdk1
Cdk1
Product competes with ATP.
Reversible: yes
Target IC50: 2 µM for anti-proliferative properties in HeLa cells; 5.8 µM against Cdk1/cyclin B
Embalagem
Packaged under inert gas
Advertência
Toxicity: Standard Handling (A)
Reconstituição
Following reconstitution aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Outras notas
Andreani, A., et al. 2000. Anticancer Drug Des.15, 447.
Andreani, A., et al. 1996. Anticancer Res.16, 3585.
Andreani, A., et al. 1996. Anticancer Res.16, 3585.
Informações legais
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Código de classe de armazenamento
10-13 - German Storage Class 10 to 13
Certificados de análise (COA)
Busque Certificados de análise (COA) digitando o Número do Lote do produto. Os números de lote e remessa podem ser encontrados no rótulo de um produto após a palavra “Lot” ou “Batch”.
Já possui este produto?
Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.
Stefanie Schmetsdorf et al.
The European journal of neuroscience, 29(6), 1096-1107 (2009-03-24)
Cyclins and cyclin-dependent kinases (Cdks) are the main components that control the orderly progression through cell cycle. In the mature nervous system, terminally differentiated neurons are permanently withdrawn from cell cycle, as mitotic quiescence is essential for the functional stability
Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.
Entre em contato com a assistência técnica